참고문헌
- Alao, J.P. 2007. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6:24.
- Baba, T., D. Hirose, N. Sasaki, N. Watanabe, N. Kobayashi, Y. Kurashige, F. Karimi and T. Ban. 2016. Mycorrhizal Formation and Diversity of Endophytic Fungi in Hair Roots of Vaccinium oldhamii Miq. in Japan. Microbes. Environ. 31:186-189. https://doi.org/10.1264/jsme2.ME16011
- Balcerczak, E., G. Pasz-Walczak, P. Kumor, M. Panczyk, R. Kordek, R. Wierzbicki and M. Mirowski. 2005. Cyclin D1 protein and CCND1 gene expression in colorectal cancer. Eur. J. Surg. Oncol. 31:721-726. https://doi.org/10.1016/j.ejso.2005.04.005
- Baldin, V., J. Lukas, M.J. Marcote, M. Pagano and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821. https://doi.org/10.1101/gad.7.5.812
- Chao, D.L., C.A. Sanchez, P.C. Galipeau, P.L. Blount, T.G. Paulson, D.S. Cowan, K. Ayub, R.D. Odze, P.S. Rabinovitch and B.J. Reid. 2008. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin. Cancer Res. 14:6988-6995. https://doi.org/10.1158/1078-0432.CCR-07-5063
- Diehl, J.A., M. Cheng, M.F. Roussel and C.J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12: 3499-3511. https://doi.org/10.1101/gad.12.22.3499
- Diehl, J.A., F. Zindy and C.J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972. https://doi.org/10.1101/gad.11.8.957
- Gillett, C., V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes and G. Peters. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1812-1817.
- Hirotoshi, T., K. Hisato, K.T. Ryoko, N. Kazuo, Y. Masao, K. Haruki and Y. Chizyko. 2013. Antioxidant activities and anti-cancer cell proliferation properties of Natsuhaze (Vaccinium oldhamii Miq.), Shashanbo (V. bracteatum Thunb.) and Blueberry cultivars. Plants 2:57-71. https://doi.org/10.3390/plants2010057
- Hunter, T and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582. https://doi.org/10.1016/0092-8674(94)90543-6
- Joo, H.G. 2003. Altered maturation of dendritic cells by taxol, an anticancer drug. J. Vet. Sci. 4:229-234.
- Jung, K.W., Y.J. Won, H.J. Kong and E.S. Lee. 2018. Prediction of Cancer Incidence and Mortality in Korea, 2018. Cancer Res. Treat. 50:317-323. https://doi.org/10.4143/crt.2018.142
- Karjalainen, E., T. Sarjala and H. Raitio. 2010. Promoting human health through forests: overview and major challenges. Environ. Health Prev. Med. 15:1-8. https://doi.org/10.1007/s12199-008-0069-2
- Kris-Etherton, P.M., K.D. Hecker, A. Bonanome, S.M. Coval, A.E. Binkoski, K.F. Hilpert, A.E. Griel and T.D. Etherton. 2002. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113:71S-88S. https://doi.org/10.1016/S0002-9343(01)00995-0
- Kristt, D., I. Turner, R. Koren, E. Ramadan and R. Gal. 2000. Overexpression of cyclin D1 mRNA in colorectal carcinomas and relationship to clinicopathological features: an in situ hybridization analysis. Pathol. Oncol. Res. 6:65-70. https://doi.org/10.1007/BF03032661
- Kwak, Y.T., R. Li, C.R. Becerra, D. Tripathy, E.P. Frenkel and U.N. Verma. 2005. IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J. Biol. Chem. 280:33945-33952. https://doi.org/10.1074/jbc.M506206200
- Lee, J.H., K.T. Lee, J.H. Yang, N.I. Baek and D.K. Kim. 2004. Acetylcholinesterase inhibitors from the twigs of Vaccinium oldhami Miquel. Arch. Pharm. Res. 27:53-56. https://doi.org/10.1007/BF02980046
- Mahadevappa, R and H.F. Kwok. 2017. Phytochemicals - A novel and prominent source of anti-cancer drugs against colorectal cancer. Comb. Chem. High Throughput Screen. 20:376-394.
- Mhawech, P., V. Greloz, C. Oppikofer, I. Szalay-Quinodoz and F. Herrmann. 2004. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Cancer 100:2367-2375. https://doi.org/10.1002/cncr.20306
- Moreno-Bueno, G., S. Rodriguez-Perales, C. Sanchez-Estevez, R. Marcos, D. Hardisson, J.C. Cigudosa and J. Palacios. 2004. Molecular alterations associated with cyclin D1 overexpression in endometrial cancer. Int. J. Cancer 110: 194-200. https://doi.org/10.1002/ijc.20130
- Musgrove, E.A., C.E. Caldon, J. Barraclough, A. Stone and R.L. Sutherland. 2011. Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer 11:558-572. https://doi.org/10.1038/nrc3090
- Oh, S.J. and S.C. Koh. 2009. Screening of antioxidative activity and a-amylase inhibitory activity in angiosperm plants native to Jeju Island. Korean J. Plant Res. 22:71-77.
- Okabe, H., S.H. Lee, J. Phuchareon, D.G. Albertson, F. McCormick and O. Tetsu. 2006. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS One 1:e128. https://doi.org/10.1371/journal.pone.0000128
- Park, S.B., G.H. Park, H.M. Song, H.J. Son, Y. Um, H.S. Kim, J.B. Jeong. 2017. Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells. BMC Complement. Altern. Med. 17:445. https://doi.org/10.1186/s12906-017-1954-2
- Russell, A., M.A. Thompson, J. Hendley, L. Trute, J. Armes and D. Germain. 1999. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18:1983-1991. https://doi.org/10.1038/sj.onc.1202511
- Seybt, T.P., P. Ramalingam, J. Huang, S.W. Looney and M.D. Reid. 2012. Cyclin D1 expression in benign and differentiated malignant tumors of the thyroid gland: diagnostic and biologic implications. Appl. Immunohistochem. Mol. Morphol. 20:124-130. https://doi.org/10.1097/PAI.0b013e31822d4783
- Siegel, R.L., K.D. Miller and A. Jemal. 2018. Cancer statistics, 2018. CA: Cancer J. Clin. 68:7-30. https://doi.org/10.3322/caac.21442
- Stendahl, M., A. Kronblad, L. Ryden, S. Emdin, N.O. Bengtsson and G. Landberg. 2004. Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br. J. Cancer. 90: 1942-1948. https://doi.org/10.1038/sj.bjc.6601831
- Tan, P.G., Z. Xing and Z.Q. Li. 2004. Expression of cyclin D1 in brain gliomas and its significance. Chin. J. Cancer. 23:63-65.
- Thoms, H.C., M.G. Dunlop and L.A. Stark. 2007. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67:1660-1669. https://doi.org/10.1158/0008-5472.CAN-06-1038
- Uhari, M., T. Kontiokari, M. Koskela and M. Niemela. 1996. Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ 313:1180-1184. https://doi.org/10.1136/bmj.313.7066.1180
- Wall, M.E. and M.C. Wani. 1995. Camptothecin and taxol: discovery to clinic-thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 55:753-760.
- Wu, M.Y., C.X. Zhuang, H.X. Yang and Y.R. Liang. 2004. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J. Gastroenterol.10:476-480. https://doi.org/10.3748/wjg.v10.i4.476